ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer

被引：8
|
作者：
Fan, Zhiyao [1 ,2 ,3 ,4 ]
Luo, Guopei [1 ,2 ,3 ,4 ]
Gong, Yitao [1 ,2 ,3 ,4 ]
Liu, Chen [1 ,2 ,3 ,4 ]
Yu, Xianjun [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Pancreat Canc Inst, Shanghai, Peoples R China
[4] Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / 10期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1245/s10434-020-08335-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：4026 / 4027
页数：2
相关论文
共 50 条
  • [1] ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer
    Zhiyao Fan
    Guopei Luo
    Yitao Gong
    Chen Liu
    Xianjun Yu
    Annals of Surgical Oncology, 2020, 27 : 4026 - 4027
  • [2] Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer
    Fan, Zhiyao
    Luo, Guopei
    Gong, Yitao
    Xu, He
    Qian, Yunzhen
    Deng, Shengming
    Huang, Qiuyi
    Yang, Chao
    Cheng, He
    Jin, Kaizhou
    Liu, Chen
    Yu, Xianjun
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (10) : 4017 - 4025
  • [3] Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer
    Zhiyao Fan
    Guopei Luo
    Yitao Gong
    He Xu
    Yunzhen Qian
    Shengming Deng
    Qiuyi Huang
    Chao Yang
    He Cheng
    Kaizhou Jin
    Chen Liu
    Xianjun Yu
    Annals of Surgical Oncology, 2020, 27 : 4017 - 4025
  • [4] Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients
    Junjie Hang
    Peng Xue
    Haiyan Yang
    Shaobo Li
    Donghui Chen
    Lifei Zhu
    Weiyi Huang
    Shujuan Ren
    Yue Zhu
    Liwei Wang
    Scientific Reports, 7
  • [5] Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients
    Hang, Junjie
    Xue, Peng
    Yang, Haiyan
    Li, Shaobo
    Chen, Donghui
    Zhu, Lifei
    Huang, Weiyi
    Ren, Shujuan
    Zhu, Yue
    Wang, Liwei
    SCIENTIFIC REPORTS, 2017, 7
  • [6] Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer
    Okugawa, Yoshinaga
    Toiyama, Yuji
    Yamamoto, Akira
    Shigemori, Tsunehiko
    Ide, Shozo
    Kitajima, Takahito
    Fujikawa, Hiroyuki
    Yasuda, Hiromi
    Hiro, Junichiro
    Yoshiyama, Shigeyuki
    Yokoe, Takeshi
    Saigusa, Susumu
    Tanaka, Koji
    Shirai, Yumiko
    Kobayashi, Minako
    Ohi, Masaki
    Araki, Toshimitsu
    McMillan, Donald C.
    Miki, Chikao
    Goel, Ajay
    Kusunoki, Masato
    ANNALS OF SURGERY, 2020, 272 (02) : 342 - 351
  • [7] Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer A meta-analysis
    Zang, Ye
    Fan, Yu
    Gao, Zhenjun
    MEDICINE, 2020, 99 (23)
  • [8] Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer''
    Zhang, Qu-xia
    Xu, Bin-bin
    Xue, Zhen
    ANNALS OF SURGERY, 2021, 274 (06) : E689 - E690
  • [9] Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer
    Tsujiura, Masahiro
    Yamamoto, Akira
    Imaoka, Hiroki
    Shimura, Tadanobu
    Kitajima, Takahito
    Morimoto, Yuhki
    Kawamura, Mikio
    Yasuda, Hiromi
    Okita, Yoshiki
    Yokoe, Takeshi
    Okugawa, Yoshinaga
    Ohi, Masaki
    Toiyama, Yuji
    SURGICAL ONCOLOGY-OXFORD, 2022, 44
  • [10] C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study
    Demirkol, Muhammed Emin
    Aktas, Gulali
    Bilgin, Satilmis
    Kahveci, Gizem
    Kurtkulagi, Ozge
    Atak, Burcin Meryem
    Duman, Tuba Taslamacioglu
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (06): : 838 - 841
12345